# Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)

> **NCT03190005** · — · COMPLETED · sponsor: **Taipei City Hospital** · enrollment: 35 (actual)

## Conditions studied

- Stable Angina

## Interventions

- **DRUG:** clopidogrel
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03190005
- **Lead sponsor:** Taipei City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03190005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03190005, "Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03190005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
